Latest Breaking News On - Berlin cures expands research capabilities - Page 1 : comparemela.com

03.04.2024 - BERLIN, GERMANY / ACCESSWIRE / April 3, 2024 / Berlin Cures, a biotechnology company in Phase II clinical trial for a treatment against Long COVID, appoints six distinguished scientists to a new advisory board. The aim of the board is to advise on .

Friedemann paulChristian mardinCarl erbJohn mcmurrayCarmen scheibenbogenStephane heymansBerlin cures expands research capabilitiesUniversity of glasgowBerlin cures holdingUniversity hospital erlangenCures expands research capabilitiesScientific expertiseNew advisory boardBerlin curesVice deanHeart failure research